首页> 外文期刊>Infection and Drug Resistance >Successful control of resistance in Pseudomonas aeruginosa using antibiotic stewardship and infection control programs at a Chinese university hospital: a 6-year prospective study
【24h】

Successful control of resistance in Pseudomonas aeruginosa using antibiotic stewardship and infection control programs at a Chinese university hospital: a 6-year prospective study

机译:在一家中国大学医院使用抗生素管理和感染控制计划成功控制了铜绿假单胞菌的耐药性:一项为期6年的前瞻性研究

获取原文
           

摘要

Objective: Pseudomonas aeruginosa is emerging as a highly multidrug-resistant (MDR) nosocomial pathogen. Data on the efficacy of infection control measures in endemic situations are lacking. We investigated the effect of antimicrobial stewardship (AMS) and infection control programs (ICPs) in controlling the resistance of P . aeruginosa at a tertiary hospital center. Methods: Susceptibility and resistance were investigated using broth microdilution, as per the guidelines of the Clinical and Laboratory Standards Institute. Antibiotic use was restricted through AMS, which included a classification management system for antibiotic use. The ICPs included environmental cleaning and disinfection, hand hygiene, active surveillance of P . aeruginosa , and education about infection control. Results: A total of 2,241 P . aeruginosa isolates were evaluated between 2012 and 2017. Sensitivity and resistance of the isolates to the antipseudomonal antimicrobials colistin and tigecycline were stable. The sensitivity and resistance to other antipseudomonal antimicrobials improved after 2014, after the AMS and ICPs were implemented in 2013. The use of alcohol-based hand gel significantly increased from 0.6 to 10.9?L per 1,000 patient-days (PD) during the study period ( P =0.005). The incidence rates of extensively drug-resistant (XDR) and MDR P . aeruginosa showed a sustained decrease from 2013 (4.9 and 22%) to 2017 (1 and 15%), respectively. The yearly consumption of antimicrobial agents also showed a sustained and significant decrease from 45 defined daily doses (DDDs) per 1,000 PD to 38.15 DDDs per 1,000 PD ( P =0.04). A significant correlation was found between the incidence rate of MDR P . aeruginosa and the consumption of antimicrobial agents ( P =0.01). Conclusion: Monitoring of P . aeruginosa , AMS, and comprehensive ICPs could be one of the best and effective methods to prevent the development of resistance in P . aeruginosa .
机译:目的:铜绿假单胞菌(Pseudomonas aeruginosa)是一种高度耐多药(MDR)的医院病原体。缺乏关于流行病情况下感染控制措施功效的数据。我们调查了抗菌素管理(AMS)和感染控制程序(ICPs)在控制P耐药性方面的作用。一家三级医院中心的铜绿。方法:按照临床和实验室标准协会的指南,使用肉汤微量稀释法研究药敏性和耐药性。 AMS限制了抗生素的使用,其中包括用于抗生素使用的分类管理系统。 ICP包括环境清洁和消毒,手部卫生,对P的积极监测。铜绿,以及有关感染控制的教育。结果:共2,241 P。在2012年至2017年之间对铜绿假单胞菌分离物进行了评估。分离物对抗假性抗菌素大肠菌素和替加环素的敏感性和耐药性稳定。在2013年实施AMS和ICPs之后,2014年之后对其他抗假性抗菌药物的敏感性和耐药性有所改善。在研究期间,使用酒精基手凝胶的比例从每1,000个患者日(PD)的0.6升至10.9?L显着增加(P = 0.005)。广泛耐药性(XDR)和MDR P的发生率。从2013年(4.9%和22%)到2017年(1%和15%)的铜绿持续下降。年度抗菌药物消费量也显示出持续且显着的减少,从每1,000 PD的45每日定义剂量(DDD)降至每1,000 PD的38.15 DDD(P = 0.04)。发现MDR P的发生率之间存在显着相关性。铜绿假单胞菌和抗菌药物的消耗(P = 0.01)。结论:P的监测。铜绿假单胞菌,AMS和综合ICPs可能是预防P.铜绿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号